Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.05 +1.37%   SPY: 134.54 +1.40%
Discuss Index Tracked By  


  Track the *RXSTM Index  

Stem Cell Stocks (*RXSTM)

  Stem Cell Ideas       Stem Cell Performance       Stem Cell Community  
 
Popular long ideas:
Popular short ideas:
Top dividend plays:
Pro favorites:
STEM, GERN, ASTM
GERN, PSTI, CYTX
None
BTX
 
Index Description: These companies have significant exposure to developing medical treatments using stem cells
     
Today:
1-month:
All-time:
+0.4%
+2.0%
+49.3%
vs S&P 500:
vs S&P 500:
vs S&P 500:
-1.0%
-3.4%
+52.0%
Data since: Jan-01-2008
 
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
$106.8M
13.3
0.0%
     
549 members Tracking
Share this Index on Facebook
Share this Index on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
 
All Time
 
 
 
 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View     Ideas & Research    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Alerts
 ASTM $2.00 0.00 0.0% 207,454 102% $77.2M - 14% -42% No Alerts/News
 ATHX $1.90 +0.03 +1.6% 225,256 269% $44.6M - 90% -39% 2 Alerts (1 News) - View
 BTX $5.95 0.00 0.0% 150,091 52% $291.2M - 68% -28% No Alerts/News
 CUR $1.02 0.00 0.0% 82,940 101% $49.6M - 19% -57% No Alerts/News
 CYTX $4.20 +0.22 +5.5% 886,072 177% $230.3M - 121% -50% 2 Alerts (0 News) - View
 GERN $2.08 +0.06 +2.7% 1,247,046 89% $272.9M - 54% -60% No Alerts/News
 ISCO $0.48 -0.01 -2.1% 42,043 19% $38.0M - 30% -72% No Alerts/News
 KOOL $1.07 +0.06 +5.9% 39,565 43% $17.5M - 53% -71% No Alerts/News
 NBS $0.67 +0.04 +6.5% 487,466 115% $67.2M - 56% -68% No Alerts/News
 OPXA $0.95 -0.04 -3.9% 31,250 54% $22.0M - 7% -62% No Alerts/News
 OSIR $5.95 +0.11 +1.9% 63,661 69% $195.3M - 44% -29% 1 Alert (0 News) - View
 PSTI $2.60 +0.04 +1.6% 48,993 74% $111.7M - 31% -29% No Alerts/News
 STEM $1.07 0.00 0.0% 926,425 141% $15.2M - 53% -89% 1 Alert (0 News) - View
Is this index incomplete or incorrect?
Got an idea for a new Index?
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Positive Data Presented on Athersys' MultiStem to Treat Stroke
ATHX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 03, 10:52AM from (www.globenewswire.com)
CLEVELAND and NEW ORLEANS, Feb. 3, 2012 (GLOBE NEWSWIRE) -- Medical researchers from The University of Texas Health Science  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
StemCells, Inc. Receives FDA Authorization for Age-Related Macular Degeneration Clinical Trial
STEM  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 02, 09:00AM from (www.globenewswire.com)
NEWARK, Calif., Feb. 2, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that the U.S. Food and Drug  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Athersys Announces Positive Results of MultiStem(R) Clinical Trial for Hematopoietic Stem Cell Transplant Support and Prevention of Graft-Versus-Host Disease
ATHX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 01, 03:00PM from (www.globenewswire.com)
CLEVELAND, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced positive results from its Phase  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Athersys Awarded $3.6 Million in Grant Funding for Stem Cell Product Development
ATHX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - February 01, 07:00AM from (www.globenewswire.com)
CLEVELAND, Ohio, Feb. 1, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX), a leader in the emerging field of regenerative  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
StemCells, Inc. Announces Publication of Preclinical Data Demonstrating Its Human Neural Stem Cells Preserve Vision
STEM  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 30, 09:00AM from (www.globenewswire.com)
NEWARK, Calif., Jan. 30, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced the publication of preclinical  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Greek Default? Investors Just Ready to Move On
EMC  HOG  BTX  EFOI  DGX  COH  
Linked by tickerspy Newswire ( track newsfeed | ignore newsfeed ) - January 24, 04:37PM from (www.tickerspy.com)
Despite mixed earnings news, stocks traded modestly lower on the day, although the Nasdaq did manage to squeeze out a small  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Stem Cell Study May Show Advance
GERN  
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - January 23, 12:57PM from (feeds.nytimes.com)
A treatment for eye diseases derived from human embryonic stem cells might have improved the vision of two patients, bolstering  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Pluristem Awarded a $2.4 Million Grant From Israeli Government
PSTI  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 18, 05:00AM from (www.globenewswire.com)
HAIFA, Israel, Jan. 18, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), today announced  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
DiagnoCure announces fourth quarter 2011 and year-end results
CUR  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - January 16, 04:01PM


QUEBEC CITY, Jan. 16, 2012 /PRNewswire/ - DiagnoCure, Inc. (TSX: CUR), a
 more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
StemCells, Inc. to Present at Biotech Showcase 2012
STEM  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 09, 09:00AM from (www.globenewswire.com)
NEWARK, Calif., Jan. 9, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Athersys to Present at 2012 Biotech Showcase(TM)
ATHX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 05, 12:32PM from (www.globenewswire.com)
CLEVELAND, Jan. 5, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it will present at the 2012  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
DiagnoCure to host Q4 2011 and full year earnings conference call and webcast
CUR  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - January 05, 07:00AM


QUEBEC CITY, Jan. 5, 2012 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR), a
 more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Athersys Receives U.S. Patent Covering the Treatment of Cardiovascular Disease With Adult Stem Cells
ATHX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - January 04, 07:00AM from (www.globenewswire.com)
CLEVELAND, Jan. 4, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it has been granted U.S. patent  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
International Stem Cell Corporation - "How Is Parthenogenesis Done?
ISCO  
Linked by pjbosc ( track member | ignore member ) - December 29, 01:24PM from (intlstemcell.blogspot.com)
San Diego Research Ethics Consortium
Salk Institute for Biological Studies
Parthenogenetic stem cell lines: Ethical considerations
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
With S&P Near Flat for 2011, Money Managers May Push for Positive Territory
CALM  CSC  BTX  SHLD  SOL  MJN  
Linked by tickerspy Newswire ( track newsfeed | ignore newsfeed ) - December 27, 04:31PM from (www.tickerspy.com)
Stocks came out of the Christmas break to post mixed results on a relatively quiet day, as a better-than-expected consumer  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Big Holiday Winners in Tech, Energy
EK  RMBS  BRCM  NOA  SD  CUR  
Linked by tickerspy Newswire ( track newsfeed | ignore newsfeed ) - December 23, 10:13AM from (www.tickerspy.com)
In morning trading, the Oil Sands Stocks Index was the top performing tickerspy Index on the day, led by North American Energy  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Portfolio Managers Could Push Shares Higher to Close the Year
AM  BTX  YHOO  TIBX  AKAM  HSOL  
Linked by tickerspy Newswire ( track newsfeed | ignore newsfeed ) - December 22, 04:36PM from (www.tickerspy.com)
Stocks had a solid day, as the economic data was largely positive. Jobless claims continue to trend lower, while consumer  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
StemCells, Inc. Announces Closing of Public Offering of Common Stock and Warrants
STEM  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - December 22, 09:00AM from (www.globenewswire.com)
NEWARK, Calif., Dec. 22, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it has closed its previously  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tech Carnage, But Otherwise Not All Bad
NKE  PAYX  BTX  KMX  ORCL  HZNP  
Linked by tickerspy Newswire ( track newsfeed | ignore newsfeed ) - December 21, 04:45PM from (www.tickerspy.com)
While the tech sector was unable to escape the wrath of investors after Oracle's (ORCL) poor quarter, the broader market  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Catastrophic Success
BTX  GALT  
Linked by The Big Picture ( track newsfeed | ignore newsfeed ) - December 20, 10:00PM from (www.ritholtz.com)
Catastrophic Success John Mauldin December 20, 2011 ~~~ New readers to my musings often find it interesting, when they meet  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 36



Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
tickerspy Indexes use a "net asset value" calculation. The components are equally weighted at the inception of the Index (typically 1/1/2008) and over time as some stocks go up and others go down, the relative weights of the components shift accordingly.
Click to close X

We look at the recent net stock adds (people adding a stock to their portfolio minus people removing it) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. Without the company history comparison, our most followed companies would likely be near the top of the list at all times. A value greater than one indicates a greater than normal number of adds over the last seven days, and a value less than one indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

We look at the recent net stock shorts (people shorting it in their portfolios minus people covering their short) and compare against the company's previous history to identify those companies that are seeing the largest changes on a relative basis. A value less than -1 (for example -3.6) indicates a greater than normal number of shorts over the last seven days, and a value greater than -1 (for example -0.6) indicates a less than normal number of adds. If no value is shown, there was not enough activity to generate a value.

Click to close X

Thanks for helping us keep tickerspy Indexes accurate!

Let us know which tickers should be added or removed from the Stem Cell Stocks Index (*RXSTM).

Note: Our tickerspy research team will look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.


Click to close X

Got an idea for an Index we don't have listed? Send it, and our research team will consider it for inclusion.

Note: Our tickerspy research team look at all recommendations but not all of them will be implemented. As a general rule, stocks with a market cap below $50 million will not be included.

Index Name

Tickers(separate with spaces or commas)

Additional comments